© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
iRhythm Technologies, Inc. (IRTC) stock surged +1.10%, trading at $111.75 on NASDAQ, up from the previous close of $110.53. The stock opened at $111.01, fluctuating between $111.01 and $117.03 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | 111.01 | 117.03 | 111.01 | 111.75 | 1.23M |
| Sep 21, 2026 | 109.22 | 111.38 | 107.92 | 110.38 | 385.08K |
| Sep 18, 2026 | 112.05 | 112.46 | 108.58 | 109.33 | 674.12K |
| Sep 17, 2026 | 112.47 | 113.45 | 111.19 | 111.75 | 365.44K |
| Sep 16, 2026 | 111.84 | 114.22 | 111.13 | 111.82 | 479.69K |
| Sep 15, 2026 | 113.79 | 115.16 | 110.81 | 111.88 | 452.26K |
| Sep 14, 2026 | 113.17 | 115.48 | 112.45 | 114.72 | 606.28K |
| Sep 11, 2026 | 114.82 | 116.01 | 110.20 | 111.43 | 524.57K |
| Sep 10, 2026 | 118.08 | 121.55 | 112.33 | 112.88 | 727.29K |
| Sep 09, 2026 | 121.19 | 124.91 | 119.03 | 119.57 | 978.83K |
| Sep 08, 2026 | 121.38 | 123.93 | 119.94 | 122.24 | 479.77K |
| Sep 04, 2026 | 121.47 | 123.52 | 120.57 | 123.07 | 444.47K |
| Sep 03, 2026 | 124.43 | 125.35 | 120.78 | 123.43 | 430.06K |
| Sep 02, 2026 | 121.83 | 125.86 | 121.63 | 122.49 | 338.41K |
| Sep 01, 2026 | 119.45 | 124.72 | 117.45 | 122.35 | 597.75K |
| Aug 31, 2026 | 118.62 | 119.93 | 115.77 | 118.94 | 480.68K |
| Aug 28, 2026 | 117.23 | 121.20 | 115.04 | 120.25 | 439.36K |
| Aug 27, 2026 | 117.66 | 120.38 | 115.98 | 116.33 | 402.57K |
| Aug 26, 2026 | 121.24 | 122.63 | 117.59 | 119.15 | 467.75K |
| Aug 25, 2026 | 124.34 | 125.62 | 122.50 | 123.09 | 353.48K |
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
| Employees | 2400 |
| Beta | 1.32 |
| Sales or Revenue | $492.68M |
| 5Y Sales Change% | 1.617% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |